G1 Therapeutics Inc (GTHX)
4.09
-0.13
(-3.08%)
USD |
NASDAQ |
May 24, 16:00
4.11
+0.02
(+0.49%)
After-Hours: 20:00
G1 Therapeutics Total Long Term Debt (Quarterly): 43.09M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 43.09M |
| December 31, 2023 | 51.56M |
| September 30, 2023 | 51.25M |
| June 30, 2023 | 50.94M |
| March 31, 2023 | 77.47M |
| December 31, 2022 | 77.02M |
| September 30, 2022 | 76.56M |
| June 30, 2022 | 76.10M |
| Date | Value |
|---|---|
| March 31, 2022 | 75.65M |
| December 31, 2021 | 75.19M |
| September 30, 2021 | 30.27M |
| June 30, 2021 | 30.09M |
| March 31, 2021 | 29.91M |
| December 31, 2020 | 19.89M |
| September 30, 2020 | 19.67M |
| June 30, 2020 | 19.45M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
19.45M
Minimum
Jun 2020
77.47M
Maximum
Mar 2023
50.26M
Average
51.09M
Median
Total Long Term Debt (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 388.39M |
| Geron Corp | 82.74M |
| Palatin Technologies Inc | -- |
| Oragenics Inc | -- |
| TG Therapeutics Inc | 101.33M |